VYNE Therapeutics Inc

8-K Other events Jul 30, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Regulation FD disclosure Jul 28, 2026 8-K Regulation FD disclosure; Other events Jul 21, 2026 8-K Shareholder vote results Jul 20, 2026 8-K Regulation FD disclosure Jul 14, 2026 8-K Regulation FD disclosure; Other events Jul 10, 2026 8-K Regulation FD disclosure May 21, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Delisting notice or listing-rule failure Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Entered a material agreement Jan 30, 2026 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Dec 17, 2025 8-K Shareholder vote results Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Delisting notice or listing-rule failure Sep 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Director or officer change Aug 14, 2025 8-K Results of operations (earnings release); Other events Jul 30, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Other events Jan 13, 2025 8-K Other events Dec 23, 2024 8-K Director or officer change; Shareholder vote results Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 1, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Director or officer change; Regulation FD disclosure Jan 3, 2024 8-K Director or officer change; Shareholder vote results Dec 13, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Unregistered sale of equity; Item 5.08; Regulation FD disclosure; Other events Oct 30, 2023